Transgene SA
F:TGNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Transgene SA
F:TGNA
|
FR |
|
Sopra Steria Group SA
OTC:SPPSY
|
FR |
|
Next Biometrics Group ASA
F:NT7
|
NO |
|
F
|
Fresnillo PLC
BMV:FRES
|
MX |
|
T
|
Telkom Indonesia (Persero) Tbk PT
F:TCID
|
ID |
|
B
|
Bank of Nova Scotia
F:BKN
|
CA |
|
D
|
Danaher Corp
XMUN:DAP
|
US |
|
M
|
Morgan Stanley
SWB:DWD
|
US |
|
S
|
Sonoco Products Co
F:SNS
|
US |
|
D
|
Dollar General Corp
F:7DG
|
US |
|
Singapore Airlines Ltd
SGX:C6L
|
SG |
|
M
|
Mitsubishi Electric Corp
XBER:MIE1
|
JP |
|
Biosig Technologies Inc
NASDAQ:STEX
|
US |
|
B
|
Bank of Communications Co Ltd
SWB:C4C
|
CN |
|
A
|
African Rainbow Capital Investments Ltd
JSE:AIL
|
MU |
|
F
|
Federal National Mortgage Association
DUS:FNM
|
US |
|
C
|
Corcept Therapeutics Inc
SWB:HTD
|
US |
|
I
|
Icade SA
F:3IC
|
FR |
|
R
|
Rolls-Royce Holdings PLC
F:RRU
|
UK |
|
Scatec ASA
F:66T
|
NO |
|
Shinkin Central Bank
TSE:8421
|
JP |
|
K
|
Kubota Corp
DUS:KUO1
|
JP |
|
C
|
CH Robinson Worldwide Inc
XBER:CH1A
|
US |
|
S
|
SoftBank Group Corp
F:SFT
|
JP |
Bankruptcy Probability
Transgene SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Transgene SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Transgene SA
PAR:TNG
|
213.9m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Transgene SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Transgene SA has total debt of 1.7m EUR. This includes both short-term (0 EUR) and long-term (1.7m EUR) debt.
You can find a full breakdown on its Balance Sheet.
